SEC Form 4 · accession 0001209191-15-009822
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael N Needle
Officer — Chief Medical Officer
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F1 | $1.07 | Feb 3, 2015 | A | 500,000 | A | — | Feb 3, 2025 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1This option will vest as to 25% of the shares on January 9, 2016 and in thirty-six equal monthly installments thereafter as to the remaining shares through January 9, 2019.